|1.||de Maat, Moniek P M: 4 articles (03/2013 - 03/2008)|
|2.||Vos, Hans L: 4 articles (11/2009 - 12/2005)|
|3.||Leebeek, Frank W G: 3 articles (03/2013 - 03/2008)|
|4.||Cheung, Elim Y L: 3 articles (11/2009 - 03/2008)|
|5.||Bertina, Rogier M: 3 articles (06/2009 - 12/2005)|
|6.||Uitte de Willige, Shirley: 3 articles (06/2009 - 12/2005)|
|7.||Rosendaal, Frits R: 2 articles (05/2011 - 12/2005)|
|8.||Renner, Wilfried: 2 articles (10/2010 - 01/2007)|
|9.||Pilger, Ernst: 2 articles (10/2010 - 01/2007)|
|10.||Fan, Bing-Lin: 2 articles (07/2009 - 03/2004)|
|1.||Hepatocellular Carcinoma (Hepatoma)
03/01/2004 - "This study was to explore cloning and identification of fibrinogen gamma polypeptide (FGG) gene differentially expressed in human hepatocellular carcinoma. "
03/01/2004 - "[Cloning and identification of fibrinogen gamma polypeptide (FGG) gene differentially expressed in human hepatocellular carcinoma]."
07/01/2009 - "Abnormal expression of fibrinogen gamma (FGG) and plasma level of fibrinogen in patients with hepatocellular carcinoma."
|2.||Colorectal Neoplasms (Colorectal Cancer)
05/01/2011 - "Our results did not support an effect of PAI-1 4G/5G, MTHFR 677C>T, and fibrinogen gamma 10034C>T on colorectal cancer risk. "
05/01/2011 - "Factor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu (rs5985) were genotyped in 1,801 patients with colorectal cancer and 1,853 healthy controls from a large German population-based study. "
08/27/2009 - "The observed negative correlation of genetic VT risk with the plasma levels of the fibrinogen gamma' variant suggests that FGG-H2 and -H3 haplotypes modify thrombosis risk by controlling the level of this FGG splice isoform."
03/01/2013 - "Fibrinogen γ' and variation in fibrinogen gamma genes in the etiology of portal vein thrombosis."
12/15/2005 - "Multivariate analysis showed that reduced fibrinogen gamma' levels and elevated total fibrinogen levels were both associated with an increased risk for thrombosis, even after adjustment for FGG-H2. "
08/01/2012 - "SNP in the following genes demonstrated association with thrombosis risk overall in the discovery or replication cohorts and were assessed using metaanalytic methods: factor V Leiden (FVL) rs6025 (OR 1.85, p = 0.02) and methylenetetrahydrofolate reductase (MTHFR) rs1801133 (OR 0.75, p = 0.04) in whites, and fibrinogen gamma (FGG) rs2066865 (OR 1.91, p = 0.01) in Hispanic Americans. "
03/15/2004 - "To define better the contribution of fibrinogen to large vessel thrombus formation, we studied carotid artery thrombosis in wild-type mice, mice lacking fibrinogen (fbg-/-), mice treated with 7E9 (a blocking antibody to the fibrinogen gamma-chain C-terminus), and mice expressing a mutant fibrinogen (gamma delta 5) that lacks the gamma-chain platelet-binding motif QADGV. "
|4.||Venous Thrombosis (Deep-Vein Thrombosis)
08/27/2009 - "Previous case-control studies showed that genetic variation in the fibrinogen gamma gene (FGG) increased the risk for deep vein thrombosis (VT) in adults. "
01/01/2007 - "Recently, a haplotype-tagging single nucleotide polymorphism characterized by a C to T substitution at nucleotide 10034 of the fibrinogen gamma gene (FGG 10034C>T, rs2066865), has been proposed as a novel risk factor for deep venous thrombosis (DVT). "
01/01/2007 - "The fibrinogen gamma (FGG) 10034C>T polymorphism is associated with venous thrombosis."
12/15/2005 - "Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels."
06/01/2007 - "Fibrinogen gamma haplotype 2 (FGG-H2) is associated with reduced fibrinogen gamma' levels and fibrinogen gamma'/total fibrinogen ratios and with an increased deep-venous thrombosis (DVT) risk. "
04/01/2007 - "The present case-control study searched for potential determinants of the plasma fibrinogen gamma' concentration and examined the relationship between this variant and risk of myocardial infarction (MI). "
02/01/2006 - "Haplotypes of the fibrinogen gamma gene do not affect the risk of myocardial infarction."
04/01/2008 - "Despite intensive investigation, there is no clear evidence for a role of variations in the genes coding for the fibrinogen-alpha, fibrinogen-beta, and fibrinogen-gamma polypeptide chains in myocardial infarction. "
04/01/2007 - "Elevated plasma fibrinogen gamma' concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors."
03/01/2006 - "An intricate interplay between the genes encoding fibrinogen gamma (FGG), alpha (FGA) and beta (FGB), coagulation factor XIII (F13A1) and interleukin 6 (IL6) and environmental factors is likely to influence plasma fibrinogen concentration, fibrin clot structure and risk of myocardial infarction (MI). "
|1.||Factor XIII (Coagulation Factor XIII)
|2.||factor V Leiden
|3.||Plasminogen Activator Inhibitor 1
|4.||Prothrombin (Factor II)
|5.||Fibrinogen (Factor I)
|7.||Proteins (Proteins, Gene)
|9.||Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)
|10.||Peptide Elongation Factor 1 (1, EF)